Moxibustion combined with characteristic lifestyle intervention of Traditional Chinese Medicine in the treatment of abdominal obesity: A study protocol for a randomized controlled trial

Li-Hua Wang, Wei Huang, Wei Zhou, Li Zhou, Xiao-Li Zhou, Peng Zhou, Yan Yan, Zhong-Yu Zhou, Hua Wang, Li-Hua Wang, Wei Huang, Wei Zhou, Li Zhou, Xiao-Li Zhou, Peng Zhou, Yan Yan, Zhong-Yu Zhou, Hua Wang

Abstract

Background: Abdominal obesity occurs when excessive visceral and subcutaneous fat is built up around the abdomen and stomach, which negatively impacts human health. Moxibustion, arose from Traditional Chinese Medicine (TCM), has been widely applied in the treatment of abdominal obesity. Several studies have shown the positive effects of moxibustion in prevention and treatment of endocrine issues and excess body weight. In this context, our study aims to examine the safety and efficacy of the combination of moxibustion and characteristic lifestyle intervention of TCM in the treatment of abdominal obesity.

Methods/design: This study will be a multicenter, randomized, controlled trial conducted from September 2020 to January 2022 that includes 150 participants who have abdominal obesity and meet the eligibility criteria. The participants will be randomly divided into 3 groups in a 2:2:1 allocation ratio. The intervention group will receive moxibustion combined with characteristic lifestyle intervention of TCM; the other group will receive moxibustion combined with lifestyle intervention; the control group will receive lifestyle intervention only. Eight-week moxibustion sessions will be provided to participants assigned to the 2 intervention groups. The characteristic lifestyle intervention of TCM will also last 8 weeks, whereas the lifestyle intervention will last 12 weeks including 8-week treatment period, 4-week follow-up period. The primary outcome is the waist circumference measured by a tape measure. The secondary outcomes include obesity-related indicators, serum biochemical indexs, blood pressure, conversion score of physical symptoms, and measurement of the scale. Adverse events will be recorded during the treatment and follow-up period.

Discussion: The results are expected to provide clinical evidence for the application of the combination of moxibustion and characteristic lifestyle intervention of TCM in patients with abdominal obesity.

Trial registration: ClinicalTrials.gov, NCT04501198, Registered on 9 June 2020.

Conflict of interest statement

The authors report no conflicts of interest.

Figures

Figure 1
Figure 1
Flowchart of the trial.

References

    1. Agha M, Agha R. The rising prevalence of obesity: part a: impact on public health. Int J Surg Oncol 2017;2:e17.
    1. Pi-Sunyer X. The medical risks of obesity. Postgrad Med 2009;121:21–33.
    1. Procaccini C, Santopaolo M, Faicchia D, et al. Role of metabolism in neurodegenerative disorders. Metabolism 2016;65:1376–90.
    1. Mazon JN, de Mello AH, Ferreira GK, et al. The impact of obesity on neurodegenerative diseases. Life Sci 2017;182:22–8.
    1. World Health Organization: Obesity and overweight. Available at: . Accessed March 25, 2019.
    1. Janghorbani M, Amini M, Willett WC, et al. First nationwide survey of prevalence of overweight, underweight, and abdominal obesity in Iranian adults. Obesity 2007;15:2797–808.
    1. Rajan TM, Menon V. Psychiatric disorders and obesity: a review of association studies. J Postgrad Med 2017;28:69.
    1. Zhang C, Rexrode KM, van Dam RM, et al. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation 2008;117:1658–67.
    1. Bujalska IJ, Kumar S, Stewart PM. Does central obesity reflect “Cushing's disease of the omentum”. Lancet 1997;349:1210–3.
    1. Beleigoli AM, Andradade AQ, Cançado AG, et al. Web-based digital health interventions for weight loss and lifestyle habit changes in overweight and obese adults: systematic review and meta-analysis. J Med Internet Res 2019;21:e298.
    1. Sherrington A, Newham JJ, Bell R, et al. Systematic review and meta-analysis of internet-delivered interventions providing personalized feedback for weight loss in overweight and obese adults. Obes Rev 2016;17:541–51.
    1. Coons MJ, DeMott A, Buscemi J, et al. Technology interventions to curb obesity: a systematic review of the current literature. Curr Cardiovasc Risk Rep 2012;6:120.
    1. Seki Y, Kasama K, Yasuda K, et al. Metabolic surgery for inadequately controlled type 2 diabetes in non-severely obese Japanese: a prospective, single center study. Surg Obes Relat Dis 2018;14:978–85.
    1. Pournaras Dimitri J, Hardwick RH, le Roux Carel W. Gastrointestinal surgery for obesity and cancer: 2 sides of the same coin. Surg Obes Relat Dis 2017;13:720–1.
    1. Nam HK, Lee KH. Small for gestational age and obesity: epidemiology and general risks. Ann Pediatr Endocrinol Metab 2018;23:9–13.
    1. Asia Pacifc Cohort Studies Collaboration. The burden of overweight and obesity in the Asia–Pacifc region. Obes Rev 2007;8:191–6.
    1. Hsieh CH, Tseng CC, Shen JY, et al. Randomized controlled trial testing weight loss and abdominal obesity outcomes of moxibustion. Biomed Eng Online 2018;17:149.
    1. Vickers A, Zollman CC. ABC of complementary medicine: acupuncture. BMJ 1999;319:973–6.
    1. Wang HB, Li XH, He YW, et al. Effect of preventive acupuncture and preventive moxibustion in Guanyuan (CV4) on contents of ACTH, NE, and 5-HT in menopausal rat. Journal of Beijing University of Traditional Chinese Medicine 2008;31:45–52.
    1. Koh YJ, Lee JH, Park SY. Moxibustion-simulating bipolar radiofrequency suppresses weight gain and induces adipose tissue browning via activation of UCP1 and FGF21 in a mouse model of diet-induced obesity. Evid Based Complement Alternat Med 2018;2018:4737515.
    1. Mestre Luis M, Dickinson Stephanie L, Golzarri-Arroyo L, et al. Data anomalies and apparent reporting errors in ’Randomized controlled trial testing weight loss and abdominal obesity outcomes of moxibustion’. Biomed Eng Online 2020;19:11.
    1. Huang D, Liu Z, Xu B, et al. Effect of acupuncture and moxibustion on severe obesity complicated with hyperlipidemia in different genders. Zhongguo Zhen Jiu 2018;38:685–9.
    1. Garvey WT, Mechanick JI, Brett EM, et al. American association of clinical endocrinologists and American college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract 2016;22:1.
    1. Chinese society of traditional Chinese Medicine. Classification and judgment of TCM Constitution (ZYYXH/T157-2009). World Journal of Integrated Chinese and Western Medicine 2009;4:303–4.
    1. Name and location of acupoints. Beijing, China: China Standard Press; 2006.
    1. Instituto Nacional de Salud Pública (INSP) Encuesta Nacional de Salud y Nutrición Medio Camino 2016.
    1. Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006;444:881–7.
    1. Yusuf S, Hawken S, Ôunpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 2004;364:937–52.
    1. Razay G, Vreugdenhil A, Wilcock G. Obesity, abdominal obesity and alzheimer disease. Dement Geriatr Cogn Disord 2006;22:173–6.
    1. Valenzuela R, Videla LA. The importance of the long-chain polyunsaturated fatty acid n-6/n-3 ratio in development of non-alcoholic fatty liver associated with obesity. Food Funct 2011;2:644–8.
    1. Levy E, Levy P, Le Pen C, et al. The economic cost of obesity: The French situation. Int J Obes 1995;19:788–92.
    1. Dobbs R, Sawers C, Thompson F, et al. Overcoming Obesity: An Initial Economic Analysis. Jakarta, Indonesia: McKinsey Global Institute; 2014.
    1. Li WQ, Jiang W, Liu J. Treatment of simple obesity patients with phlegm dampness stagnation syndrome with warming needle moxibustion. Zhen Ci Yan Jiu 2018;43:522–5.
    1. Ren BB, Liu ZC, Xu B. Observation on the efficacy of female obesity complicated with climacteric syndrome treated by acupuncture and moxibustion. Zhongguo Zhen Jiu 2012;32:871–6.
    1. Zazai R, Wilms B, Ernst B, et al. Sagittal abdominal diameter does not predict metabolic traits better than waist circumference-related measures of abdominal obesity in obese subjects. Exp Clin Endocrinol Diabetes 2018;126:619–27.
    1. Franik G, Bizoń A, Włoch S, et al. The effect of abdominal obesity in patients with polycystic ovary syndrome on metabolic parameters. Eur Rev Med Pharmacol Sci 2017;21:4755–61.
    1. Zhang HW, Lin ZX, Cheung F, et al. Moxibustion for alleviating side effects of chemotherapy or radiotherapy in people with cancer. Cochrane Database Syst Rev 2018;11:CD010559.
    1. Morell-Azanza L, Ojeda-Rodríguez A, Ochotorena-Elicegui A, et al. Changes in objectively measured physical activity after a multidisciplinary lifestyle intervention in children with abdominal obesity: a randomized control trial. BMC Pediatr 2019;19:90.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel